Czech defence group CSG sees shares halve from January peak despite record orders, new execs, and solid H1 results.

The Danish pharmaceutical giant is fighting on several fronts at once—and the market can't seem to agree on whether that's a ...

D-Wave's Q2 loss more than doubled to $54.7M, revenue flat at $3.1M, CFO departs, but tech milestones continue.

Two Primary Hydrogen directors cancel C$10,000 in units from July placement, while stock rallies 112% on new project staking ...

There is a peculiar disconnect playing out at Rocket Lab right now. On one side of the ledger sits a company executing with ...

European Lithium's takeover by Critical Metals shifts to a variable share ratio, with court hearing Sept 15 and completion ...

There is a curious tension at Micron Technology right now. The memory maker is committing to a ten-year research vision and ...

Rheinmetall invests €270M in Kassel plant, but shares fall 2.1% as investors question order-to-revenue conversion amid €80.5B ...

Vanguard's All-World UCITS ETF nears $80B in assets, cuts fees to save investors $37M annually; top-10 concentration eases as tech weights shift.

Investors poured fresh capital into Europe's semiconductor ETF complex at the very moment the sector's main benchmark was absorbing its sharpest daily decline i ...

Evotec's core operations grew 28% in H1 2026, but revenue fell 19% and EBITDA turned negative. Guidance confirmed, shares near decade low.

The chemical giant's flagship Ludwigshafen site has long depended on the Rhine as its commercial lifeline. With river levels now scraping historic lows, BASF is ...